Tags |
|
|
Links |
|
|
I Suggest - Would You Give Away Your Business?
A Business Exit Plan can have a number of different connotations. You may hear it referred to as a Succession Plan.
At Superb Coaching we have taken a deliberate stance in focussing on the ‘EXIT’ because we are dealing with the business owner’s plan to remove themselves from the business. Yes, there are issues around succession management that we address ho
At Superb Coaching we have taken a deliberate stance in focussing on the ‘EXIT’ because we are dealing with the business owner’s plan to remove themselves from the business. Yes, there are issues around succession management that we address ho
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
wever we feel that the Exit Plan needs to address more than just succession.
Your Business Exit Plan should deliver the following objectives:
1) To maximising the capital realisation from the transfer of ownership
2) To achieve this realisation in a reasonable time frame
3) To minimise the risks as consequence of change or during the pe
Your Business Exit Plan should deliver the following objectives:
1) To maximising the capital realisation from the transfer of ownership
2) To achieve this realisation in a reasonable time frame
3) To minimise the risks as consequence of change or during the pe
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
riod of change
In a survey conducted by the Australian CPA in 2004, it was found of business owners gave the following reasons for undertaking a plan.
In a survey conducted by the Australian CPA in 2004, it was found of business owners gave the following reasons for undertaking a plan.
- Age (21%)
- New business opportunities (11%)
- Forward planning/looking to the future (11%)
- Good business practice/l
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ogic/common sense (9%)Succession/business for children/need it to continue (8%) Wanted to make more money / opportunity to grow (7%) View to retirement (6%) Wanted to sell out/been in it too long (5%) Wanted to get it ri
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ght this time/needed direction (3%)Need time with family/death in family (2%) Low business performance (2%) The work overload (2%) Family break-up (2%) GST too much/taxation purposes (1%) Ill
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ness (1%)No real reason (5%) In other research conducted in the UK, a number of leading factors were identified as contributing to SMB exit failure. These included.
· Businesses with lifestyle and personal rather than strategic goals
· Poor business performance
· Managerial dependence on owner
·
· Businesses with lifestyle and personal rather than strategic goals
· Poor business performance
· Managerial dependence on owner
·
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
Ignoring the need to make arrangements for exiting
In Australia we have some 40% of SMB’s totally dependent on the owner.
So what are your options for exiting the business?
The following were found as being the most appealing by SMB owners themselves.
In Australia we have some 40% of SMB’s totally dependent on the owner.
So what are your options for exiting the business?
The following were found as being the most appealing by SMB owners themselves.
- Sell or pass on to a child or another family member (25%)
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
interestingly, if we compare the above same list where the business owner was advised by a professional we observe the following preferences.
- Advertise the business for sale without identifying a buyer (43%)
- Sell or pass on to a child or another family member (30%)
- A trade sale to someone in
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
the industry (17%)Sell to management or staff (3%) Close the business and sell the assets (3%) Don’t know (4%) Of significance is the fact that 43% of owners surveyed planned for an on-going income stream from the business after exit. This is a double-
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
dged sword.
Not only do owners want to maximise the value of the sale value, but they are also looking for an income stream to support their future lifestyle.
It becomes apparent that apart from the broad range of matters that need to be addressed, maximising the value of the business is paramount to anyone considering exiting from their business.
The exp
Not only do owners want to maximise the value of the sale value, but they are also looking for an income stream to support their future lifestyle.
It becomes apparent that apart from the broad range of matters that need to be addressed, maximising the value of the business is paramount to anyone considering exiting from their business.
The exp
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
erience of Australian CPA’s has found that the barriers to SMB’s maximising business valuation included:
· The business is too dependent on the owner
· The business costs are too high
· Out-of-date technology
· Processes are not documented
· The business owner is not prepared to commit time preparing for a sale
· A lack of potential buyers
· The business is too dependent on the owner
· The business costs are too high
· Out-of-date technology
· Processes are not documented
· The business owner is not prepared to commit time preparing for a sale
· A lack of potential buyers
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
· The business does not achieve a reasonable return
· The owner has unrealistic expectations about the value of the business
So what can You do to maximise the value of your business and any on-going income stream you might be looking for?
You need to develop your Business Exit Plan ensuring that it is integrated into your bus
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
iness’ strategic plans. You need to involve yourself, your family and your staff. Most importantly, you need to plan ahead.
At Superb Coaching we focus on implementing 7 Key Strategies for our clients.
1. PLANNING We firstly ensure that our clients have a current Business Plan that is being actioned.
At Superb Coaching we focus on implementing 7 Key Strategies for our clients.
1. PLANNING We firstly ensure that our clients have a current Business Plan that is being actioned.
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
We then address the matter of the Business Exit Plan.
2. STRUCTURE Does your business have the right structure supported by a culture of leadership and team development fostering the business objectives?
3. FUNCTIONALITY Do you have the right people sitting in the right seats on the right bus? Are
2. STRUCTURE Does your business have the right structure supported by a culture of leadership and team development fostering the business objectives?
3. FUNCTIONALITY Do you have the right people sitting in the right seats on the right bus? Are
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
lines of responsibility clearly defined and followed? Does the business have points of individual dependence?
4. SYSTEMS Are the business systems supporting the operations? Are they effectively utilised and do they work in with the business processes? Are there effective performance measurement systems in place?
5.
Yes, profit, turnover, financial ratios and asset value are critical as well, but these generally are what are referred to as “lagging indicators”. They only tell you about what has happened in the past, the history of the business.
To maximise your business value, you should also pay attention to demonstrating the “future” potential of t
4. SYSTEMS Are the business systems supporting the operations? Are they effectively utilised and do they work in with the business processes? Are there effective performance measurement systems in place?
5.
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
>PROCESSES
Are the systems and processes appropriately documented? Are the business policies and procedures up to date and understood by the staff?
6. DISTRIBUTION Does your business effectively apply relationship management to select partner businesses for building your customer base? Are there opportunities
6. DISTRIBUTION Does your business effectively apply relationship management to select partner businesses for building your customer base? Are there opportunities
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
to attract better qualified customers and increase turnover?
7. POSITIONING Your success in the market will be driven by the market’s perception of what your business is really about. Acknowledgement of your position can only be achieved by ensuring that your business is totally aligned to this position in everything it does.
7. POSITIONING Your success in the market will be driven by the market’s perception of what your business is really about. Acknowledgement of your position can only be achieved by ensuring that your business is totally aligned to this position in everything it does.
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
Yes, profit, turnover, financial ratios and asset value are critical as well, but these generally are what are referred to as “lagging indicators”. They only tell you about what has happened in the past, the history of the business.
To maximise your business value, you should also pay attention to demonstrating the “future” potential of t
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
he business. This is achieved by measuring “leading indicators”.
Adopt the 7 Key Strategies and you can be assured that you will be delivering to the future potential of your business.
Now your business is really appealing to a potential investor or buyer. They have assurance over past performance and confidence in future capacity
Adopt the 7 Key Strategies and you can be assured that you will be delivering to the future potential of your business.
Now your business is really appealing to a potential investor or buyer. They have assurance over past performance and confidence in future capacity
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.isuggest.org.ua/article/588/isuggest-Would-You-Give-Away-Your-Business.html">Would You Give Away Your Business?</a>
BB link (for phorums):
[url=http://www.isuggest.org.ua/article/588/isuggest-Would-You-Give-Away-Your-Business.html]Would You Give Away Your Business?[/url]
Related Articles:
Unlock the Hidden Steps to Signing On a New Client
Special Lubrication And High Performance Lubricants
Bookmark it:
|